Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutchs pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nations first cancer prevention research program, as well as the clinical coordinating center of the Womens Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
The Saha Laboratory for Liver Cancer Research is accepting applications for a Research Technician position. The laboratory uses basic and translational research approaches to explore pathogenic mechanisms and novel targeted therapies in cholangiocarcinoma, a highly lethal malignancy of the liver bile ducts. Successful candidates will learn to generate and exploit a series of fundamental cancer model systems including genetically engineered murine models (GEMMs), patient-derived xenografts and novel human cancer cell lines.
In addition, the incumbent will have the opportunity to become involved with all the steps of research being completed by the group and contribute to publications, with the ultimate goal of translating their findings into novel clinical trials for cholangiocarcinoma patients. Scientific methodologies and areas of focus include animal models and murine genetics, molecular biology, cell biology and metabolism, proteomics, biochemistry, pharmacology, and genomics. The experience gained in the lab will useful for pursuing a career as a researcher or physician.
A bachelors degree in biology, molecular biology, biochemistry or related fields.
The ideal candidate will be detail-oriented, organized, and able to work independently as well as part of a team in a challenging environment.
Excellent communication and organizational skills are necessary.
Significant research experience outside of coursework (less than two years for research technician I and more than two years of professional experience for research technician II).
Experience with mammalian cell culture and mouse models is desirable.
Please apply by submitting your CV, a brief letter of intent (less than one page), and a list of three references. Recent college graduates are encouraged to apply.
We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at email@example.com or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.